The fat that can be seen and pinched is subcutaneous. It is located right under the skin and is usually located around the hips, thighs, arms, and abdomen. Though surplus fat in the body may cause ...

The FDA rejected AstraZeneca's subcutaneous Saphnelo application, delaying U.S. approval until 2026, despite positive clinical trial results. The subcutaneous formulation allows self-administration, ...

A Prescription Drug User Fee Act target date of May 24, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License ...

The full results of a phase 3 clinical trial showed that patients with moderate-to-severe active systemic lupus erythematosus (SLE) who received standard treatment achieved greater reductions in ...

Subcutaneous (SC) formulations of monoclonal antibodies are rapidly transforming the delivery of cancer immunotherapy. Designed to replace or complement intravenous (IV) administration, SC delivery ...

Please provide your email address to receive an email when new articles are posted on . Knee crepitus was associated with osteoarthritis risk at 1-year post-ACL reconstruction. However, crepitus did ...

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium Subcutaneous amivantamab-lazertinib demonstrated noninferior ...

Intro: Cardiac tamponade is a common cause of obstructive shock, often necessitating urgent intervention. We delineate a rare case of cardiac tamponade and shock due to tension pneumomediastinum (TP).

Please provide your email address to receive an email when new articles are posted on . Patients who received subcutaneous amivantamab-vmjw every 4 weeks plus lazertinib had similar outcomes as those ...

Jamon Couch receives funding from an Australian government Research Training Program scholarship. Adam Culvenor receives funding from The National Health and Medical Research Council and Medibank ...

Noisy knees after an ACL injury may raise fears of impending arthritis, but new research shows that these noises signal existing damage and not future decline, helping patients and clinicians separate ...

TORONTO -- An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of lecanemab (Leqembi) for maintenance treatment in early Alzheimer's disease, ...